Guest View
User: Pass: | become a member
Posts Tagged ‘RDY’

Generic Drug Makers

Here’s another terrific post by Pharmboy, this time discussing Generic Drug Makers. - Ilene

Generic Drug Makers

Variety of Pills

Courtesy of Pharmboy

Coming to the end of a good year, and good riddance for some!  Whilst the market has been irrational for some time, it is not about what we think but rather about what others that have money think.  I have my notions, and here are a few companies that may do well in the New Year with a passed health care reform bill.

I really like the generic market right now. With patents expiring you can literally gauge how much a generic will make based on the patents expiring in the next few months. These generics are the vultures that follow the in a pack of lions.  They have a good way of scavenging for their food and vultures have a distinct relationship with the lions.  They may not come up with the drugs but they are definitely going to make a nice margin from them.  But the competition is fierce these days, and competitors in the generic market include Watson (WPI), Teva (TEVA) , Dr Reddy’s Labs (RDY), Hi-Tech Pharmacal (HITK), Par Pharmaceuticals (PRX), and Caraco (CPD).

First up, Mylan Pharmaceuticals (MYL) - I know that Phil has liked Teva in the past and I have noted Mylan (#3 in generics), WPI and RDY (pre-GSK rumors).  Currently, Mylan has blown through its 52 week high so is it still a buy?  In short answer, yes.  Mylan’s future comes from a swath of FDA approvals that have come in over the past few months.

  1. August 27, 2009 Mylan Begins Marketing First Generic Version of BenzaClin(R) Acne Treatment
  2. August 18, 2009 Mylan’s Matrix Receives First and Only Tentative FDA Approval Under PEPFAR for Generic Version of Atripla(R) HIV Treatment
  3. August 10, 2009 Mylan Receives FDA Approval for Generic Version of Migraine Treatment Imitrex(R)
  4. July 20, 2009 Mylan Receives FDA Approval for Additional Strengths of the Antipsychotic Haloperidol— Key News from the article. Currently, Mylan has 119 ANDAs pending FDA approval representing $84.7 billion in annual brand sales, according to IMS Health. Thirty-five of these pending ANDAs are potential first-to-file opportunities, representing $16.6 billion in annual brand sales, according to IMS Health.
  5. July 16, 2009 Mylan Receives FDA Approval for Generic Version of Thyroid Deficiency Treatment Cytomel
  6. July 7, 2009 Mylan Receives FDA Approval for Generic Version of Prostate Cancer Treatment Casodex
  7. June 17, 2009 Mylan Receives FDA Approval for Additional Strength of Generic…
    continue reading

Tags: , , , , ,



 

Phil's Favorites

The Ugly Americans: Wall Street Excluded from European Government Bond Sales

Well, well, well, karma works in mysterious ways. - Ilene

The Ugly Americans: Wall Street Excluded from European Government Bond Sales  

Courtesy of JESSE'S CAFÉ AMÉRICAIN

It will be interesting if Asia and South America pick up this theme of banning the Wall Street banks on ethical considerations. 

The cheating going on in the financial markets is really getting to be outrageous. 

Guardian UK
...



more from Ilene

Zero Hedge

Ethanol Boondoggle Gets a Second Life

Courtesy of madhedgefundtrader

One of my biggest disappointments with Obama so far is his continued support of the ethanol boondoggle. The program was ramped up by the Bush administration to achieve energy independence by subsidizing the production of alcohol from domestically grown corn. Add clean burning moonshine (yes, it’s the same alcohol—C2H5OH), whose combustion products are carbon dioxide (CO2) and water (H2O), to gasoline and emissions also go down.

The irony is that if you include all the upstream and downstream inputs, the process consumes far more energy than it produces. It also demands massive quantities of fresh water, which someday will become more valuable than the oil the ethanol is supposed to replace, turning it into toxic waste.

Few consumers are aware of how big the ethanol industry has grown in such a short period. Ethanol consumption of corn has soared fro...



more from Tyler

Chart School

Stock Market Commentary: Selling into the Close

Stock Market Commentary: Selling into the Close

Courtesy of Fallond Stock Picks 

It was looking very good for bulls until about 2:30pm when profit takers swooped in as the usual market worries kept optimism tamed. The watch areas for bulls are the breakout gaps; one from last Friday and a second from last Monday. more from Chart School

Trading Goddess

Toppy Tuesday - Happy Anniversary Bull Market!

It's hard to believe that just one year ago today investors thought the world was ending!


Well, not all investors - we were BUYBUYBUYing at the time, as I recapped back in September whan we did our "Market Crash - Year One Review." Click on Cramer's picture for the Daily Show's March 4th, 2009 review of the magical moments that led us down to the bottom and here's another great video from the evening broadcast on March 9th and, of course, there is my own legendary appearance on ...



more from Goddess

Oxen Group Trades

The Oxen Report: Oil and Market Look Down, We Continue Our Bear Approach

As many of you have probably read, one year ago was the lowest we got to in the stock market. Today is also the anniversary of my stock picking beginnings. Its my one year anniversary. In t...



more from David

The Options Report

By Andrew Wilkinson


Covered-Call Sellers Make Note of Exits on American Airlines Parent Corp.

Today’s tickers: AMR, AIG, C, GME, HD, XLP, ALL, CMC, QLGC & YUM

AMR - AMR Corp. – Bullish investors engaged in covered-call selling on AMR Corporation this afternoon after its subsidiary, American Airlines, revealed February passenger unit revenue increased between 6.5% to 7.5% as compared to roughly the same time a year ago. The so-called buy-write strategy took off amid an 11% rally in the price of the underlying stock to $9.93. Options traders sold approximately 16,300 calls at the March $11 strike for an average premium of $0.09 apiece, and simultaneously purchased an equivalent number of AMR-shares when the stock was trading at approximately $9.84 each. The net price paid per AMR-share amounts to $9.75 apiece because of the $0.09 per contract financing provided by the sale of the call options. Investors utilizing the...



more from Andrew

Insider Zone


INSIDER SELLING HITS NEW 2010 HIGH

Update on insider activity from Pragcap -- selling still far exceeds buying, confirming my thoughts on Feb. 20 that trends haven't changed. - Ilene 

INSIDER SELLING HITS NEW 2010 HIGH

Courtesy of The Pragmatic Capitalist 

The recent uptick in stocks has not been met with much enthusiasm by corporate insiders.  In fact, pessimism rules the day in the land of insider buying and selling trends.  For the week ending February 26th insiders sold a total of $1.88...


http://www.insidercow.com/ more from Insider

OpTrader


Swing trading portfolio - Week of March 8th, 2010

This post is for live trades and daily comments. 

To learn more about the swing trading portfolio (strategy, membership etc.), please click here

- Optrader

...

more from OpTrader


March 2010
M T W T F S S
« Feb «-»  
1234567
891011121314
15161718192021
22232425262728
293031  

Locations of visitors to this page

FeedTheBull - Top Stock market and Finance Sites

As Seen On:




About Phil:

Philip R. Davis is a founder Phil's Stock World, a stock and options trading site that teaches the art of options trading to newcomers and devises advanced strategies for expert traders...

Learn more About Phil >>

About Ilene:

Ilene is editor and affiliate program coordinator for PSW. She manages the Favorites backup site (blogroll, archives, more). Contact Ilene to learn about our affiliate and content sharing programs.

Favorites Site >>